GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002260412 | Liver | Cirrhotic | regulation of cell morphogenesis | 127/4634 | 309/18723 | 1.45e-10 | 7.44e-09 | 127 |
GO:004424212 | Liver | Cirrhotic | cellular lipid catabolic process | 82/4634 | 214/18723 | 6.91e-06 | 1.08e-04 | 82 |
GO:001604212 | Liver | Cirrhotic | lipid catabolic process | 112/4634 | 320/18723 | 2.31e-05 | 3.03e-04 | 112 |
GO:009758111 | Liver | Cirrhotic | lamellipodium organization | 40/4634 | 90/18723 | 3.48e-05 | 4.26e-04 | 40 |
GO:190274511 | Liver | Cirrhotic | positive regulation of lamellipodium organization | 19/4634 | 37/18723 | 4.39e-04 | 3.57e-03 | 19 |
GO:190274311 | Liver | Cirrhotic | regulation of lamellipodium organization | 25/4634 | 54/18723 | 4.63e-04 | 3.75e-03 | 25 |
GO:0006643 | Liver | Cirrhotic | membrane lipid metabolic process | 69/4634 | 203/18723 | 1.89e-03 | 1.19e-02 | 69 |
GO:000166712 | Liver | Cirrhotic | ameboidal-type cell migration | 145/4634 | 475/18723 | 2.23e-03 | 1.36e-02 | 145 |
GO:00106327 | Liver | Cirrhotic | regulation of epithelial cell migration | 93/4634 | 292/18723 | 3.46e-03 | 1.92e-02 | 93 |
GO:00106317 | Liver | Cirrhotic | epithelial cell migration | 110/4634 | 357/18723 | 5.14e-03 | 2.65e-02 | 110 |
GO:00901327 | Liver | Cirrhotic | epithelium migration | 110/4634 | 360/18723 | 6.79e-03 | 3.35e-02 | 110 |
GO:00901307 | Liver | Cirrhotic | tissue migration | 111/4634 | 365/18723 | 7.66e-03 | 3.61e-02 | 111 |
GO:00464341 | Liver | Cirrhotic | organophosphate catabolic process | 52/4634 | 155/18723 | 8.42e-03 | 3.91e-02 | 52 |
GO:00106346 | Liver | Cirrhotic | positive regulation of epithelial cell migration | 58/4634 | 176/18723 | 8.54e-03 | 3.96e-02 | 58 |
GO:002260422 | Liver | HCC | regulation of cell morphogenesis | 188/7958 | 309/18723 | 4.84e-11 | 1.82e-09 | 188 |
GO:004424222 | Liver | HCC | cellular lipid catabolic process | 134/7958 | 214/18723 | 2.07e-09 | 5.79e-08 | 134 |
GO:00066444 | Liver | HCC | phospholipid metabolic process | 214/7958 | 383/18723 | 7.25e-08 | 1.48e-06 | 214 |
GO:0090305 | Liver | HCC | nucleic acid phosphodiester bond hydrolysis | 152/7958 | 261/18723 | 1.90e-07 | 3.46e-06 | 152 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:003134611 | Liver | HCC | positive regulation of cell projection organization | 193/7958 | 353/18723 | 2.28e-06 | 3.08e-05 | 193 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ENPP2 | SNV | Missense_Mutation | novel | c.1153G>A | p.Asp385Asn | p.D385N | Q13822 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
ENPP2 | SNV | Missense_Mutation | | c.1754N>G | p.His585Arg | p.H585R | Q13822 | protein_coding | deleterious(0) | possibly_damaging(0.524) | TCGA-A2-A04Y-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.1307N>A | p.Thr436Asn | p.T436N | Q13822 | protein_coding | tolerated(0.22) | benign(0.124) | TCGA-A7-A6VV-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | CR |
ENPP2 | SNV | Missense_Mutation | rs746187066 | c.606N>T | p.Met202Ile | p.M202I | Q13822 | protein_coding | deleterious(0.01) | probably_damaging(0.993) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ENPP2 | SNV | Missense_Mutation | novel | c.2168N>C | p.Lys723Thr | p.K723T | Q13822 | protein_coding | tolerated(0.16) | benign(0.22) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | | c.1073N>T | p.Arg358Ile | p.R358I | Q13822 | protein_coding | deleterious_low_confidence(0.02) | possibly_damaging(0.474) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | rs746442526 | c.95N>A | p.Arg32Gln | p.R32Q | Q13822 | protein_coding | deleterious(0.01) | probably_damaging(0.968) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | | c.1450N>T | p.Arg484Cys | p.R484C | Q13822 | protein_coding | deleterious(0) | probably_damaging(0.96) | TCGA-AQ-A1H2-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | herceptin | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.1340N>T | p.Ser447Phe | p.S447F | Q13822 | protein_coding | deleterious(0) | benign(0.346) | TCGA-AR-A0TX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | | c.2741A>G | p.Glu914Gly | p.E914G | Q13822 | protein_coding | deleterious(0.02) | probably_damaging(0.94) | TCGA-BH-A0BW-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661229 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-12188 | CHEMBL1089321 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | (S)-CARBA CYCLIC-PHOSPHATIDIC ACID | CHEMBL1630084 | 21051230 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-1741 | CHEMBL483302 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 354702264 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661228 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-34937 | CHEMBL1092743 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-1698 | CHEMBL1093490 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661227 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 336446947 | ZIRITAXESTAT | |